Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 289,160 |
|
|||||
| News | - | ||||||
| Day High | 15.285 | Low High |
|||||
| Day Low | 14.98 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Innoviva Inc | INVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.27 | 1.80% | 15.26 | 16:08:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.01 | 14.98 | 15.285 | 15.27 | 14.99 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,539 | 289,160 | $ 15.14 | $ 4,377,418 | - | 11.3701 - 16.865 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:05:49 | 1 | $ 14.96 | USD |
Innoviva Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 958.53M | 63.23M | - | 310.46M | 179.72M | 2.84 | 5.33 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Innoviva News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.69 | 15.345 | 14.69 | 15.06 | 818,521 | 0.57 | 3.88% |
| 1 Month | 15.30 | 15.345 | 14.33 | 14.82 | 650,610 | -0.04 | -0.26% |
| 3 Months | 16.20 | 16.66 | 14.33 | 15.10 | 724,044 | -0.94 | -5.80% |
| 6 Months | 12.68 | 16.865 | 12.22 | 15.03 | 724,649 | 2.58 | 20.35% |
| 1 Year | 11.63 | 16.865 | 11.3701 | 14.06 | 678,337 | 3.63 | 31.21% |
| 3 Years | 11.68 | 20.7056 | 10.64 | 14.80 | 753,271 | 3.58 | 30.65% |
| 5 Years | 13.67 | 20.7056 | 7.58 | 13.94 | 716,370 | 1.59 | 11.63% |
Innoviva Description
| Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline. |
